INTR
TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
03/11/2026
Back to search
Official data from USPTO
ELANIX
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
ELANIX
ST13
US500000079212480Class
3, 5, 9, 10, 40, 42, 44
Filing
79212480
Registration
5634868
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
49
Latest update
03/12/2026
Trademark type
Word
Nice classes
3, 5, 9, 10, 40, 42, 44
Filing date
03/07/2017
Registration date
12/25/2018
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
07/11/2025
Last transaction
03/12/2026
Responsible office
United States Patent and Trademark Office
Status code
709
Official register
Principal Register
Drawing code
4
Owner type
33
Owner location
CH
Examiner
MAYES, LAURIE ANN
Law office
L10
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Elanix Biotechnologies SA
Representatives
Lisa M. DuRoss Harness, Dickey & Pierce, PLC
Technical classification
Nice Classes
Class 3Class 5Class 9Class 10Class 40Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 3
Cosmetic preparationspreparations for cleaningprotecting and maintaining in good condition various parts of the human and animal body surface; cosmetic preparations for regeneration of the skin and mucous membranes; cosmetic preparations for personal use
Class 5
Pharmaceuticalbiological or biotechnological products for curing or treating dermatologicalgynecological and orthopedic conditions namelypharmaceutical preparations for treating dermatologicalgynecological and orthopedic conditions; wound dressing containing foetal cell based/derived proteins; protein augmented surfaces for orthopaedic implantsimplantable scaffolds comprising living tissue primarily comprised of proteins; wound dressing containing foetal cell based/derived proteins for which the cells were cultured in conditions as to produce these proteins; protein augmented surfaces for orthopaedic implantsimplantable scaffolds comprising living tissue primarily comprised of proteins for orthopaedic implants; pharmaceuticalbiological or biotechnological preparationsspecialty medicated cosmetic creamswound dressingsimplantable scaffolds comprising living tissue for enhancing therapy or maintaining tissue contourcell derivatives being stem cells for medical use for tissue regeneration; pharmaceuticalbiological or biotechnological preparations for medical use for treatment ofgynecological illnesses; biological or biotechnological preparations for medical use for treatment of orthopedic injuries; Pharmaceuticalbiological or biotechnological preparations for medical use for activating cellular functions namelyfor treatment of foetal cell derived structural and adhesion proteins to alter immune responses or enhance wound healinggrowth supplements for manufacturing of cell therapies
Class 9
Software for medical applications for diagnosing and monitoring tissue healing in dermatologyorthopedicsgynecology
Class 10
Matrices for wound dressings in the nature of interactive wound dressings primarily composed of non-living tissue for medical use comprising artificial or organically derived but non-living scaffold materials alone or in combination with cells or cell derivatives to protect the skin and heal skin related conditionsburnsulcerscutssurgical incisions; Matrices for wound dressings in the nature of interactive wound dressings primarily composed of non-living tissue for medical use comprising artificial or organic gels or creams alone or in combination with non-living cell derivatives to protect the skin and heal skin related conditions burnsulcerscutssurgical incisions; Matrices for tissue regeneration in the nature of implantable dermatology scaffolds comprising artificial or non-living organic materials alone or in combination with cells or cell derivatives for maintaining tissue contour during tissue regeneration; Matrices in the nature of interactive wound dressings primarily composed of non-living tissue for medical use comprising artificial or non-living organic scaffold materials alone or in combination with cells or cell derivatives to protect gynecologic and urologic intimate zones and heal related conditionslacerationsdrynessblistering; Matrices in the nature of interactive wound dressings primarily composed of non-living tissue for medical use comprising artificial or organic gels or creams alone or in combination with cells or cell derivatives to protect gynecologic and urologic intimate zones and heal related conditionslacerationsdrynessblistering; Matrices for tissue regeneration in the nature of implantable gynecology scaffolds comprising artificial or non-living organic materials alone or in combination with cells or cell derivatives for maintaining tissue contour during tissue regeneration; Matrices for tissue regeneration comprising artificial or non-living organic scaffold materials alone or in combination with cells or cell derivatives to heal bonecartilagetendon related conditionstendinopathiesfractures; Matrices for tissue regeneration comprising artificial or organic gels or creams alone or in combination with cells or cell derivatives to heal bonecartilagetendon related conditionstendinopathiesfractures; Matrices for tissue regeneration in the nature of implantable orthopedic scaffolds comprising artificial or non- living organic materials alone or in combination with cells or cell derivatives for maintaining tissue contour during tissue regeneration
Class 40
Custom manufacture of cosmetic preparationspharmaceutical preparations and/or chemical preparations for use in industryintermediate and finished formulationssingle constituents; Custom manufacture of biological tissue and of biotechnological products for use in research; Custom manufacture of cosmetics to order and according to customer requirements; Custom manufacture for others of biological production platformsbiotechnology production platforms for protein productionmammalian and human cells for protein productionorganoid production for testing purposesto order and according to customer requirements
Class 42
Scientific research consulting services provided by consultants in the fields of pharmaceuticalbiologicalbiotechnologicalmedical and cosmetic researchpreclinical and safety assessments
Class 44
Medical services and providing of medical information in the medical field; Medical testing and analysis for diagnostic purposes; Medical consultation services provided by consultants relating to pharmaceuticalbiologicalbiotechnologicalcosmetic and medical products
Publications
History of USPTO decisions and trademark events.
49 publications found
C71T
CANCELLED SECTION 71
07/11/2025
REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
12/25/2023
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
07/11/2022
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
07/11/2022
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
07/11/2022
EWAF
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
07/11/2022
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
07/11/2022
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
07/11/2022
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
07/11/2022
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
04/26/2019
FICS
FINAL DISPOSITION NOTICE SENT TO IB
04/05/2019
FIMP
FINAL DISPOSITION PROCESSED
04/05/2019
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
03/25/2019
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
01/05/2019
R.PR
REGISTERED-PRINCIPAL REGISTER
12/25/2018
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
12/19/2018
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
12/19/2018
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
10/09/2018
PUBO
PUBLISHED FOR OPPOSITION
10/09/2018
GPNX
NOTIFICATION PROCESSED BY IB
10/06/2018
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
09/19/2018
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
09/19/2018
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
09/19/2018
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
09/04/2018
XAEC
EXAMINER'S AMENDMENT ENTERED
08/31/2018
ALIE
ASSIGNED TO LIE
08/31/2018
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
08/31/2018
GNEA
EXAMINERS AMENDMENT E-MAILED
08/31/2018
CNEA
EXAMINERS AMENDMENT -WRITTEN
08/31/2018
NREP
NEW REPRESENTATIVE AT IB RECEIVED
06/07/2018
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
03/01/2018
GNFR
FINAL REFUSAL E-MAILED
03/01/2018
CNFR
FINAL REFUSAL WRITTEN
03/01/2018
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
02/14/2018
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
02/13/2018
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
02/13/2018
RFNP
REFUSAL PROCESSED BY IB
09/01/2017
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
08/17/2017
RFRR
REFUSAL PROCESSED BY MPU
08/17/2017
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
08/01/2017
CNRT
NON-FINAL ACTION WRITTEN
07/31/2017
RFWR
NON-FINAL ACTION (IB REFUSAL) WITHDRAWN FOR REVIEW
07/29/2017
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
07/24/2017
CNRT
NON-FINAL ACTION WRITTEN
07/23/2017
MAFR
APPLICATION FILING RECEIPT MAILED
07/18/2017
DOCK
ASSIGNED TO EXAMINER
07/14/2017
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
07/14/2017
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
07/13/2017
Continuous trademark protection
Get notified about every new filing that threatens ELANIX or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.